MRK Merck & Co., Inc.
Stock Price & Overview

$132.962.24 (+1.71%)4:00 PM 06/24/24
NYSE | $USD | Pre-Market: $133.00 +0.04 (+0.03%) 7:04 AM

Charts

EPS
PE
Div Rate
Yield
Short Interest
Market Cap
Volume
Prev. Close

Quant Ranking

Ratings Summary

People Also Follow

Similar to MRK

ETFs Holding MRK

MRK Company Profile

Merck & Co., Inc. logo
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes under the Keytruda, Bridion, Adempas, Lagevrio, Belsomra, Simponi, and Januvia brands, as well as vaccine products consisting of preventive pediatric, adolescent, and adult vaccines under the Gardasil/Gardasil 9, ProQuad, M-M-R II, Varivax, RotaTeq, Live Oral, Vaxneuvance, Pneumovax 23, and Vaqta names. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. The company serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians, wholesalers, government entities, veterinarians, distributors, animal producers, farmers, and pet owners. It has development and commercialization agreement for three of Daiichi Sankyo’s deruxtecan ADC candidates, which include patritumab deruxtecan, ifinatamab deruxtecan, and raludotatug deruxtecan for the treatment of multiple solid tumors both as monotherapy and/or in combination with other treatments; and AstraZeneca PLC to co-development and co-commercialize AstraZeneca’s Lynparza products for multiple cancer types, and Koselugo for multiple indications. The company also has a collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. was founded in 1891 and is headquartered in Rahway, New Jersey.
Employees
71,000
Founded
1891
Address
  • 126 East Lincoln Avenue
  • Rahway, NJ, 07065
  • United States
Phone Number
908 740 4000

MRK Earnings Per Share

Earnings Estimates

Earnings Revisions

Valuation

Growth

Profitability

Momentum

Capital Structure

MRK Dividend Growth History

MRK Ownership

MRK Peers

Risk

Technicals

MRK Transcripts

Investor Presentations

MRK SEC Filings

MRK Income Statement

MRK Balance Sheet

MRK Cash Flow Statement

MRK Long Term Solvency

Discover More

You may be interested in:

Merck & Co., Inc. (MRK) Frequently Asked Questions

People Also Follow

Similar to MRK

ETFs Holding MRK